Medtecs International Corporation Limited(9103.TW)
No price history available.
Key financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | TWDm | 400 | 144 | 56 | 53 | 54 | 78 | 78 | N/A |
| Operating profit | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | TWDm | 132 | 17 | -29 | -21 | -22 | -5 | -5 | N/A |
| EPS reported | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Established in 1989 and headquartered in Taipei, Taiwan, Medtecs International Corporation Limited functions as a holistic provider of healthcare goods and related services. This company is globally recognized for manufacturing and supplying critical medical consumables to a diverse clientele, including healthcare distributors, pharmaceutical firms, and hospital networks. Its operational framework is divided into three distinct segments: 1. Manufacturing: This division is responsible for both the internal production and subcontracted fabrication of an extensive array of medical supplies. This range includes patient clothing, disposable surgical masks, protective boot covers, surgical gowns, underpads, adult diapers, crochet blankets, bed linens, and various types of medical bandages. 2. Hospital Services: Catering specifically to medical facilities in Taiwan and the Philippines, this segment delivers crucial support functions. Its offerings comprise hospital linen rental and comprehensive laundry services, management of hospital laundry operations, implementation of hospital automation, and the outsourcing of other non-core hospital activities. 3. Distribution: Focused on the Asia Pacific market, this segment is dedicated to selling Medtecs' own brand of medical consumables directly to hospitals, pharmacies, and individual end-users. Furthermore, it distributes a selection of medical equipment and supplies from other manufacturers, such as wheelchairs, syringes, nebulizers, and blood pressure monitors. Beyond these primary activities, Medtecs International is also actively engaged in the production, leasing, trade, and sale of woven and knitted textiles, alongside other finished textile products. The company also trades in specialized hospital textiles and garments, including pillowcases, bed sheets, gowns, and various apparel items, in addition to providing garters and other garment components. Subleasing activities form another part of its operations, and it plays a significant role in the manufacturing and provision of personal protective equipment (PPE).
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Medtecs International Corporation Limited (9103.TW)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Established in 1989 and headquartered in Taipei, Taiwan, Medtecs International Corporation Limited functions as a holistic provider of healthcare goods and related services. This company is globally recognized for manufacturing and supplying critical medical consumables to a diverse clientele, including healthcare distributors, pharmaceutical firms, and hospital networks. Its operational framework is divided into three distinct segments: 1. Manufacturing: This division is responsible for both the internal production and subcontracted fabrication of an extensive array of medical supplies. This range includes patient clothing, disposable surgical masks, protective boot covers, surgical gowns, underpads, adult diapers, crochet blankets, bed linens, and various types of medical bandages. 2. Hospital Services: Catering specifically to medical facilities in Taiwan and the Philippines, this segment delivers crucial support functions. Its offerings comprise hospital linen rental and comprehensive laundry services, management of hospital laundry operations, implementation of hospital automation, and the outsourcing of other non-core hospital activities. 3. Distribution: Focused on the Asia Pacific market, this segment is dedicated to selling Medtecs' own brand of medical consumables directly to hospitals, pharmacies, and individual end-users. Furthermore, it distributes a selection of medical equipment and supplies from other manufacturers, such as wheelchairs, syringes, nebulizers, and blood pressure monitors. Beyond these primary activities, Medtecs International is also actively engaged in the production, leasing, trade, and sale of woven and knitted textiles, alongside other finished textile products. The company also trades in specialized hospital textiles and garments, including pillowcases, bed sheets, gowns, and various apparel items, in addition to providing garters and other garment components. Subleasing activities form another part of its operations, and it plays a significant role in the manufacturing and provision of personal protective equipment (PPE).
